Kilitch Drugs (India) Ltd share price logo

Kilitch Drugs Share Price

NSE: KILITCH

BSE: 524500

Small Cap

Healthcare Sector

₹314.35

-7.35

(-2.28%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Kilitch Drugs Stock Performance

as on January 29, 2026 at 4:02 pm IST

  • Day's Low

    Day's High

    ₹312.55
    ₹325.05
    downward going graph

    0.57%

    Downside

    3.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹294.07
    ₹500.00
    downward going graph

    6.45%

    Downside

    59.06%

    Upside

    downward going graph

Kilitch Drugs share price movements today

Previous Close
₹321.70
Open
₹325.05
Volume
7,570.00
Upper Circuit
₹386.00
Lower Circuit
₹257.40
Day's Low - High
₹312.55 - ₹325.05
52 Week Low - High
₹294.07 - ₹500.00

Kilitch Drugs Historical Returns

1 Month Return
-6.28 %
3 Month Return
-18.25 %
1 Year Return
+ 0.64 %
3 Year Return
+ 113.12 %
5 Year Return
+ 264.12 %

Kilitch Drugs Fundamentals

as on January 29, 2026 at 4:02 pm IST

Market Cap

₹562.36 Cr

Return on Equity (ROE)

11.02

PE Ratio (TTM)

19.18

Return on capital employed (ROCE)

13.14

Industry PE ratio

39.98

Beta (LTM)

0.93

P/B Ratio

2.3

Dividend Yield

0

PEG Ratio

2.86

Quarterly Earnings Growth YOY

-6.62

EPS (TTM)

15.178352987229

Sector

Pharmaceuticals

Book Value

123.12

Technical Analysis

Bearish

View Technical Analysis

Kilitch Drugs Stock Valuation

as on January 29, 2026 at 4:02 pm IST

Kilitch Drugs in the last 5 years

  • Overview

  • Trends

Lowest (-986.00x)

July 3, 2019

Today (19.18x)

January 28, 2026

Industry (39.98x)

January 28, 2026

Highest (371.68x)

October 16, 2020

LowHigh

Today’s Price to Earnings Ratio: 19.18x

Kilitch Drugs (India) Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kilitch Drugs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Kilitch Drugs (India) Ltd image
Kilitch Drugs (India) Ltd
NA562.3652.82%0.6024198
Shree Ganesh Biotech India Ltd image
Shree Ganesh Biotech India Ltd
NA25.91-17.82%0.00222
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA215.28320.95%0.61870
Fabino Enterprises Ltd image
Fabino Enterprises Ltd
NA3.07-12.76%0.65NA18
Shree Ganesh Remedies Ltd image
Shree Ganesh Remedies Ltd
NA516.3939.94%0.6123108
See all

Kilitch Drugs Share Price Target

Get share price movements and forecasts by analysts on Kilitch Drugs.

Source: S&P Global Market Intelligence

Kilitch Drugs Stock’s Investor Sentiment and Interest

Search interest for Kilitch Drugs (India) Ltd Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:27% versus previous 30 day period

Kilitch Drugs (India) Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
45.48
36.56
41.2
31.79
44.82
33.45
47.47
56.17
61.23
43.14
48.92
Other Income
1.02
0.56
0.49
2.96
0.47
2.57
5.16
1.73
1.7
2.56
6.66
Total Income
46.5
37.12
41.69
34.75
45.29
36.03
52.64
57.89
62.92
45.7
55.58
Expenses
39.26
30.38
32.58
29.51
37.74
31.79
41.38
47.43
46.63
39.88
43.88
Operating Profit
6.22
6.18
8.62
2.28
7.08
1.66
6.09
8.74
14.6
3.26
5.04
Operating Profit Margin %
13.68%
16.9%
20.92%
7.17%
15.8%
4.96%
12.83%
15.56%
23.84%
7.56%
10.3%
Profit Before Interest, Tax and Depreciation
7.23
6.74
9.11
5.24
7.55
4.23
11.26
10.46
16.29
5.82
11.7
Interest
1.21
1.5
1.51
1.6
1.32
1.73
0.31
1.4
1.6
1.53
1.44
Depreciation
0.91
0.71
0.82
0.81
0.93
0.85
0.61
0.81
0.85
0.84
0.86
Profit Before Tax
5.11
4.53
6.78
2.83
5.3
1.65
10.34
8.25
13.84
3.45
9.4
Tax Paid
2.21
1.48
1.69
1.08
1.62
1.54
1.73
2.64
3.63
1.19
1.36
Profit After Tax
2.9
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
Total Net profit including share of profit / Loss from associate company
2.9
3.06
5.09
1.74
3.68
0.11
8.61
5.61
10.22
2.26
8.04
EPS
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
Actual EPS
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97
Adjusted EPS
2.24
2.1
2.87
1.81
2.19
0.81
5.25
3.63
6.33
1.84
4.97
Diluted EPS
2.29
2.15
2.93
1.85
2.24
0.83
5.36
3.71
6.47
1.88
4.97

Kilitch Drugs (India) Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
28.65
51.01
82.49
53.32
68.52
114.23
139.6
154.37
198.32
Other Income
1.14
2.88
4
4.13
2.67
2.91
2.92
4.48
11.16
Total Income
29.79
53.89
86.49
57.45
71.19
117.14
142.52
158.85
209.48
Expenses
29.35
45.73
75.48
53.12
63.33
103.87
122.03
130.22
166.85
Operating Profit
-0.7
5.28
7.01
0.2
5.19
10.36
17.57
24.15
31.47
Operating Profit Margin %
-2.44%
10.35%
8.5%
0.38%
7.57%
9.07%
12.59%
15.64%
15.87%
Profit Before Interest, Tax and Depreciation
0.44
8.16
11.02
4.32
7.86
13.28
20.48
28.63
42.63
Interest
-
-
0.38
0.72
0.75
1.2
4.92
5.93
5.04
Depreciation
9.76
2.04
2.05
2
1.99
2.47
3.55
3.35
3.11
Profit Before Tax
-9.32
6.12
8.59
1.6
5.12
9.61
12.01
19.35
34.48
Tax Paid
-0.43
0.96
4.76
0.77
1.36
3.4
3.73
5.78
9.53
Profit After Tax
-8.89
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
Total Net profit including share of profit / Loss from associate company
-8.89
5.15
3.83
0.84
3.77
6.21
8.28
13.58
24.94
EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
Actual EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6
Adjusted EPS
-6.58
3.81
2.55
0.54
2.32
4.63
6.57
8.97
16.24
Diluted EPS
-6.72
3.89
2.61
0.55
2.37
4.73
6.71
9.17
16.6

Kilitch Drugs (India) Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
17.23
1.12
1.42
0.29
4.46
45.66
5.78
2.59
-1.53
17.54
Cash Flow from Investing Activities
23.49
-1.54
-4.45
-13.98
-10.46
-37.57
-15.25
7.91
-8.15
-39.94
Cash Flow from Financing Activities
0.12
-0.04
5.51
16.85
0.85
1.61
7.03
-0.72
8.81
13.25
Net Cash Flow
-2.23
-0.45
2.48
3.17
-5.14
9.7
-2.44
9.78
-0.88
-9.16

Kilitch Drugs Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
68.25%
68.25%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
69.23%
63.77%
63.77%
Public
31.75%
31.75%
30.77%
30.77%
30.77%
30.77%
30.76%
30.77%
30.77%
30.76%
36.23%
36.23%
Total Outstanding Shares
1,55,82,319
1,55,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,60,82,319
1,74,80,782
1,74,80,782
Total Shareholders
9,522
9,573
9,002
9,062
9,525
9,620
9,920
10,139
9,749
10,379
10,929
12,043

Kilitch Drugs Corporate Actions

View detailed summary of the earnings and dividend history of Kilitch Drugs.

  • Kilitch Drugs (India) Ltd Earnings Results

    Kilitch Drugs (India) Ltd’s net profit fell -4.99% since last year same period to ₹8.19Cr in the Q2 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 170.3% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Kilitch Drugs (India) Ltd Dividends May,2019

    In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 per share on 30 May 2019 - translating a dividend yield of 0.16%.

    Read More about Dividends

Insights on Kilitch Drugs (India) Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, KILITCH stock has moved up by 0.9%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 3.03 Cr → 8.19 Cr (in ₹), with an average increase of 63.0% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 45.7 Cr → 55.58 Cr (in ₹), with an average increase of 17.8% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 36.23% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 63.77% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 17.8% return, outperforming this stock by 17.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 155.8% return, outperforming this stock by 42.6%

About Kilitch Drugs (India) Ltd

Kilitch Drugs India Ltd (KDIL) is a pharmaceutical company that was incorporated in May 1992 and has since gone public in Feb. 1994. They manufactures a range of pharmaceutical products including tablets, capsules, liquid orals, ointments, creams and injectables. They operate two divisions for OTC and ethical drugs, with additional manufacturing plants located in India, Ethiopia, Republic of Yemen and Patalganga Maharashtra, India. KDIL also provides exports for Sudan, Yemen, the Middle East, Miami and some South American countries. In 2011, they introduced a new product BENIN. In 2012, their undertakings located at Paonta Sahib in Himachal Pradesh were sold and transferred, while certain products were transferred to Akorn India Pvt. Ltd. KDIL's range of pharmaceutical services ensures safe and quality solutions for their customers.

Revenue: ₹48.92Cr as on September 2025 (Q2 FY26)
Net Profit: ₹8.04Cr as on September 2025 (Q2 FY26)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
OrganisationKilitch Drugs (India) Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOMukund P Mehta
E-voting on sharesClick here to vote

FAQs

What is Kilitch Drugs share price today?

Kilitch Drugs share price today stands at ₹314.35 as on at the close of the market. Kilitch Drugs share today touched a day high of ₹325.05 and a low of ₹312.55.

What is the 52 week high and 52 week low range for Kilitch Drugs share?

Kilitch Drugs touched a 52 week high of ₹500 and a 52 week low of ₹294.07. Kilitch Drugs share price today i.e. is closed at ₹314.35, which is -37.13% down from its 52 week high and 6.90% up from its 52 week low.

What is Kilitch Drugs's market capitalisation today?

Kilitch Drugs market capitalisation is ₹562.36 Cr as on .

How to buy Kilitch Drugs shares?

To buy Kilitch Drugs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for KILITCH or Kilitch Drugs (India) Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Kilitch Drugs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Kilitch Drugs trading volume today?

Kilitch Drugs trading volume is 7,570.00 as on . This means that 7,570.00 shares of Kilitch Drugs were bought and sold on the stock market during today's trading session.